![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
Part 1
Part 2
Part 3
Part 5
Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma. Sorafenib Tosylate Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sorafenib Tosylate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sorafenib Tosylate Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Sorafenib Tosylate Tablets key manufacturers include Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd. and CSPC Ouyi Pharmaceutical Co., Ltd., etc. Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022. Sorafenib Tosylate Tablets can be divided into 60 Pieces/Box, 120 Pieces/Box and Others,, etc. 60 Pieces/Box is the mainstream product in the market, accounting for % sales share globally in 2022. Sorafenib Tosylate Tablets is widely used in various fields, such as Hospital, Online Sale, Pharmacy and Others, etc. Hospital provides greatest supports to the Sorafenib Tosylate Tablets industry development. In 2022, global % sales of Sorafenib Tosylate Tablets went into Hospital filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sorafenib Tosylate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Bayer Cipla Beijing Yabao Biological Pharmaceutical Co., Ltd. Chongqing Yaoyou Pharmaceutical Co., Ltd. Jiangxi Shanxiang Pharmaceutical Co., Ltd. CSPC Ouyi Pharmaceutical Co., Ltd. Segment by Type 60 Pieces/Box 120 Pieces/Box Others Segment by Application Hospital Online Sale Pharmacy Others Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Sorafenib Tosylate Tablets market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sorafenib Tosylate Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sorafenib Tosylate Tablets industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Sorafenib Tosylate Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sorafenib Tosylate Tablets introduction, etc. Sorafenib Tosylate Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Sorafenib Tosylate Tablets market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
1 Sorafenib Tosylate Tablets Market Overview
1.1 Sorafenib Tosylate Tablets Product Overview
1.2 Sorafenib Tosylate Tablets Market Segment by Type
1.2.1 60 Pieces/Box
1.2.2 120 Pieces/Box
1.2.3 Others
1.3 Global Sorafenib Tosylate Tablets Market Size by Type
1.3.1 Global Sorafenib Tosylate Tablets Market Size Overview by Type (2018-2029)
1.3.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)2 Global Sorafenib Tosylate Tablets Market Competition by Company
2.1 Global Top Players by Sorafenib Tosylate Tablets Sales (2018-2023)
2.2 Global Top Players by Sorafenib Tosylate Tablets Revenue (2018-2023)
2.3 Global Top Players by Sorafenib Tosylate Tablets Price (2018-2023)
2.4 Global Top Manufacturers Sorafenib Tosylate Tablets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sorafenib Tosylate Tablets Market Competitive Situation and Trends
2.5.1 Sorafenib Tosylate Tablets Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sorafenib Tosylate Tablets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sorafenib Tosylate Tablets as of 2022)
2.7 Date of Key Manufacturers Enter into Sorafenib Tosylate Tablets Market
2.8 Key Manufacturers Sorafenib Tosylate Tablets Product Offered
2.9 Mergers & Acquisitions, Expansion3 Sorafenib Tosylate Tablets Status and Outlook by Region
3.1 Global Sorafenib Tosylate Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sorafenib Tosylate Tablets Historic Market Size by Region
3.2.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2018-2023)
3.2.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2018-2023)
3.2.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Region
3.3.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2024-2029)
3.3.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2024-2029)
3.3.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value), Price and Gross Margin (2024-2029)4 Global Sorafenib Tosylate Tablets by Application
4.1 Sorafenib Tosylate Tablets Market Segment by Application
4.1.1 Hospital
4.1.2 Online Sale
4.1.3 Pharmacy
4.1.4 Others
4.2 Global Sorafenib Tosylate Tablets Market Size by Application
4.2.1 Global Sorafenib Tosylate Tablets Market Size Overview by Application (2018-2029)
4.2.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)5 North America Sorafenib Tosylate Tablets by Country
5.1 North America Sorafenib Tosylate Tablets Historic Market Size by Country
5.1.1 North America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
5.1.3 North America Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
5.2 North America Sorafenib Tosylate Tablets Forecasted Market Size by Country
5.2.1 North America Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
5.2.2 North America Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)6 Europe Sorafenib Tosylate Tablets by Country
6.1 Europe Sorafenib Tosylate Tablets Historic Market Size by Country
6.1.1 Europe Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
6.1.3 Europe Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
6.2 Europe Sorafenib Tosylate Tablets Forecasted Market Size by Country
6.2.1 Europe Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
6.2.2 Europe Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)7 Asia-Pacific Sorafenib Tosylate Tablets by Region
7.1 Asia-Pacific Sorafenib Tosylate Tablets Historic Market Size by Region
7.1.1 Asia-Pacific Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sorafenib Tosylate Tablets Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sorafenib Tosylate Tablets Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sorafenib Tosylate Tablets Forecasted Market Size by Region
7.2.1 Asia-Pacific Sorafenib Tosylate Tablets Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sorafenib Tosylate Tablets Sales in Value by Region (2024-2029)8 Latin America Sorafenib Tosylate Tablets by Country
8.1 Latin America Sorafenib Tosylate Tablets Historic Market Size by Country
8.1.1 Latin America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
8.2 Latin America Sorafenib Tosylate Tablets Forecasted Market Size by Country
8.2.1 Latin America Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)9 Middle East and Africa Sorafenib Tosylate Tablets by Country
9.1 Middle East and Africa Sorafenib Tosylate Tablets Historic Market Size by Country
9.1.1 Middle East and Africa Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sorafenib Tosylate Tablets Forecasted Market Size by Country
9.2.1 Middle East and Africa Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Sorafenib Tosylate Tablets Products Offered
10.1.5 Bayer Recent Development
10.2 Cipla
10.2.1 Cipla Company Information
10.2.2 Cipla Introduction and Business Overview
10.2.3 Cipla Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cipla Sorafenib Tosylate Tablets Products Offered
10.2.5 Cipla Recent Development
10.3 Beijing Yabao Biological Pharmaceutical Co., Ltd.
10.3.1 Beijing Yabao Biological Pharmaceutical Co., Ltd. Company Information
10.3.2 Beijing Yabao Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
10.3.3 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
10.3.5 Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Development
10.4 Chongqing Yaoyou Pharmaceutical Co., Ltd.
10.4.1 Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information
10.4.2 Chongqing Yaoyou Pharmaceutical Co., Ltd. Introduction and Business Overview
10.4.3 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
10.4.5 Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Development
10.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
10.5.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Company Information
10.5.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Introduction and Business Overview
10.5.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
10.5.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Development
10.6 CSPC Ouyi Pharmaceutical Co., Ltd.
10.6.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
10.6.2 CSPC Ouyi Pharmaceutical Co., Ltd. Introduction and Business Overview
10.6.3 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
10.6.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sorafenib Tosylate Tablets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sorafenib Tosylate Tablets Industrial Chain Analysis
11.4 Sorafenib Tosylate Tablets Market Dynamics
11.4.1 Sorafenib Tosylate Tablets Industry Trends
11.4.2 Sorafenib Tosylate Tablets Market Drivers
11.4.3 Sorafenib Tosylate Tablets Market Challenges
11.4.4 Sorafenib Tosylate Tablets Market Restraints12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sorafenib Tosylate Tablets Distributors
12.3 Sorafenib Tosylate Tablets Downstream Customers13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables Table 1. Major Company of 60 Pieces/Box Table 2. Major Company of 120 Pieces/Box Table 3. Major Company of Others Table 4. Global Sorafenib Tosylate Tablets Sales by Type 2018 VS 2022 VS 2029 (US$ Million) Table 5. Global Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (K Units) Table 6. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Type (2018-2023) Table 7. Global Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US& Million) Table 8. Global Sorafenib Tosylate Tablets Market Share in Value by Type (2018-2023) Table 9. Global Sorafenib Tosylate Tablets Price by Type (2018-2023) & (US$/Unit) Table 10. Global Sorafenib Tosylate Tablets Sales by Type (2024-2029) & (K Units) Table 11. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Type (2024-2029) Table 12. Global Sorafenib Tosylate Tablets Sales by Type (2024-2029) & (US$ Million) Table 13. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Type (2024-2029) Table 14. Global Sorafenib Tosylate Tablets Price by Type (2024-2029) & (US$/Unit) Table 15. North America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (K Units) Table 16. North America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million) Table 17. Europe Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023) Table 18. Europe Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million) Table 19. Asia-Pacific Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023) Table 20. Asia-Pacific Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million) Table 21. Latin America Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023) Table 22. Latin America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million) Table 23. Middle East and Africa Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023) Table 24. Middle East and Africa Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million) Table 25. Global Sorafenib Tosylate Tablets Sales by Company (2018-2023) & (K Units) Table 26. Global Sorafenib Tosylate Tablets Sales Share by Company (2018-2023) Table 27. Global Sorafenib Tosylate Tablets Revenue by Company (2018-2023) & (US$ Million) Table 28. Global Sorafenib Tosylate Tablets Revenue Share by Company (2018-2023) Table 29. Global Market Sorafenib Tosylate Tablets Price by Company (2018-2023) & (US$/Unit) Table 30. Global Sorafenib Tosylate Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Sorafenib Tosylate Tablets Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sorafenib Tosylate Tablets as of 2022) Table 33. Date of Key Manufacturers Enter into Sorafenib Tosylate Tablets Market Table 34. Key Manufacturers Sorafenib Tosylate Tablets Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Sorafenib Tosylate Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029 Table 37. Global Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (K Units) Table 38. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2018-2023) Table 39. Global Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (US$ Million) Table 40. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2018-2023) Table 41. Global Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 42. Global Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (K Units) Table 43. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2024-2029) Table 44. Global Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (US$ Million) Table 45. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2024-2029) Table 46. Global Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029) Table 47. Global Sorafenib Tosylate Tablets Sales by Application: 2018 VS 2022 VS 2029 (US$ Million) Table 48. Global Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (K Units) Table 49. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Application (2018-2023) Table 50. Global Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 51. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Application (2018-2023) Table 52. Global Sorafenib Tosylate Tablets Price by Application (2018-2023) & (US$/Unit) Table 53. Global Sorafenib Tosylate Tablets Sales by Application (2024-2029) & (K Units) Table 54. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Application (2024-2029) Table 55. Global Sorafenib Tosylate Tablets Sales by Application (2024-2029) & (US$ Million) Table 56. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Application (2024-2029) Table 57. Global Sorafenib Tosylate Tablets Price by Application (2024-2029) & (US$/Unit) Table 58. North America Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) Table 59. North America Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 60. Europe Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) Table 61. Europe Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 62. Asia-Pacific Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) Table 63. Asia-Pacific Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 64. Latin America Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) Table 65. Latin America Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 66. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) Table 67. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million) Table 68. North America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units) Table 69. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023) Table 70. North America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million) Table 71. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023) Table 72. North America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units) Table 73. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029) Table 74. North America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million) Table 75. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029) Table 76. Europe Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units) Table 77. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023) Table 78. Europe Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million) Table 79. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023) Table 80. Europe Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units) Table 81. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029) Table 82. Europe Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million) Table 83. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029) Table 84. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (K Units) Table 85. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2018-2023) Table 86. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (US$ Million) Table 87. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2018-2023) Table 88. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (K Units) Table 89. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2024-2029) Table 90. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (US$ Million) Table 91. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2024-2029) Table 92. Latin America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units) Table 93. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023) Table 94. Latin America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million) Table 95. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023) Table 96. Latin America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units) Table 97. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029) Table 98. Latin America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million) Table 99. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029) Table 100. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units) Table 101. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023) Table 102. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million) Table 103. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023) Table 104. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units) Table 105. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029) Table 106. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million) Table 107. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029) Table 108. Bayer Company Information Table 109. Bayer Introduction and Business Overview Table 110. Bayer Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 111. Bayer Sorafenib Tosylate Tablets Product Table 112. Bayer Recent Development Table 113. Cipla Company Information Table 114. Cipla Introduction and Business Overview Table 115. Cipla Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 116. Cipla Sorafenib Tosylate Tablets Product Table 117. Cipla Recent Development Table 118. Beijing Yabao Biological Pharmaceutical Co., Ltd. Company Information Table 119. Beijing Yabao Biological Pharmaceutical Co., Ltd. Introduction and Business Overview Table 120. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 121. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Table 122. Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Development Table 123. Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information Table 124. Chongqing Yaoyou Pharmaceutical Co., Ltd. Introduction and Business Overview Table 125. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 126. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Table 127. Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Development Table 128. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Company Information Table 129. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Introduction and Business Overview Table 130. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 131. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Table 132. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Development Table 133. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 134. CSPC Ouyi Pharmaceutical Co., Ltd. Introduction and Business Overview Table 135. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 136. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Table 137. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development Table 138. Key Raw Materials Lists Table 139. Raw Materials Key Suppliers Lists Table 140. Sorafenib Tosylate Tablets Market Trends Table 141. Sorafenib Tosylate Tablets Market Drivers Table 142. Sorafenib Tosylate Tablets Market Challenges Table 143. Sorafenib Tosylate Tablets Market Restraints Table 144. Sorafenib Tosylate Tablets Distributors List Table 145. Sorafenib Tosylate Tablets Downstream Customers Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Sorafenib Tosylate Tablets Product Picture Figure 2. Global Sorafenib Tosylate Tablets Market Size, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global Sorafenib Tosylate Tablets Market Size Status and Outlook (2018-2029) & (US$ Million) Figure 4. Global Sorafenib Tosylate Tablets Sales Status and Outlook (2018-2029) & (K Units) Figure 5. Product Picture of 60 Pieces/Box Figure 6. Global 60 Pieces/Box Sales YoY Growth (2018-2029) & (K Units) Figure 7. Product Picture of 120 Pieces/Box Figure 8. Global 120 Pieces/Box Sales YoY Growth (2018-2029) & (K Units) Figure 9. Product Picture of Others Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 11. Global Sorafenib Tosylate Tablets Sales by Type (2018-2029) & (US$ Million) Figure 12. Global Sorafenib Tosylate Tablets Sales Market Share by Type in 2022 & 2029 Figure 13. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022 Figure 14. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022 Figure 15. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022 Figure 16. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022 Figure 17. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022 Figure 18. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022 Figure 19. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022 Figure 20. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022 Figure 21. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022 Figure 22. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022 Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Tosylate Tablets Sales in 2022 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Tosylate Tablets Revenue in 2022 Figure 25. Sorafenib Tosylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 26. Product Picture of Hospital Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units) Figure 28. Product Picture of Online Sale Figure 29. Global Online Sale Sales YoY Growth (2018-2029) & (K Units) Figure 30. Product Picture of Pharmacy Figure 31. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units) Figure 32. Product Picture of Others Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units) Figure 34. Global Sorafenib Tosylate Tablets Sales by Application (2018-2029) & (US$ Million) Figure 35. Global Sorafenib Tosylate Tablets Sales Market Share by Application in 2022 & 2029 Figure 36. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022 Figure 37. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022 Figure 38. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022 Figure 39. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022 Figure 40. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022 Figure 41. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022 Figure 42. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022 Figure 43. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022 Figure 44. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022 Figure 45. Key Raw Materials Price Figure 46. Sorafenib Tosylate Tablets Manufacturing Cost Structure Figure 47. Sorafenib Tosylate Tablets Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed
Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma. Sorafenib Tosylate Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sorafenib Tosylate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Online Sale are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sorafenib Tosylate Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Sorafenib Tosylate Tablets key manufacturers include Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd. and CSPC Ouyi Pharmaceutical Co., Ltd., etc. Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022. Sorafenib Tosylate Tablets can be divided into 60 Pieces/Box, 120 Pieces/Box and Others,, etc. 60 Pieces/Box is the mainstream product in the market, accounting for % sales share globally in 2022. Sorafenib Tosylate Tablets is widely used in various fields, such as Hospital, Online Sale, Pharmacy and Others, etc. Hospital provides greatest supports to the Sorafenib Tosylate Tablets industry development. In 2022, global % sales of Sorafenib Tosylate Tablets went into Hospital filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sorafenib Tosylate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Bayer Cipla Beijing Yabao Biological Pharmaceutical Co., Ltd. Chongqing Yaoyou Pharmaceutical Co., Ltd. Jiangxi Shanxiang Pharmaceutical Co., Ltd. CSPC Ouyi Pharmaceutical Co., Ltd. Segment by Type 60 Pieces/Box 120 Pieces/Box Others Segment by Application Hospital Online Sale Pharmacy Others Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Sorafenib Tosylate Tablets market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sorafenib Tosylate Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sorafenib Tosylate Tablets industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Sorafenib Tosylate Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sorafenib Tosylate Tablets introduction, etc. Sorafenib Tosylate Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Sorafenib Tosylate Tablets market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now